comparemela.com

Latest Breaking News On - Akoya biosciences - Page 5 : comparemela.com

Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024

Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Akoya-biosciences
Priyam-shah
Akoya-bioscience
Akoya-biosciences-inc
Nasdaq
Spatial-biology-company
Spatial-biology

Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024

MARLBOROUGH, Mass., April 22, 2024 (GLOBE NEWSWIRE) Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the first quarter

Priyam-shah
Akoya-biosciences
Akoya-bioscience
Akoya-biosciences-inc
Nasdaq
Spatial-biology-company

Spatial tumour mapping-inspired Xbox Series Xs up for auction supporting cancer research

Xbox ANZ, Cure Cancer, and University of Queensland's Dr Arutha Kulasinghe have partnered to auction off spatial tumour mapping-inspired Xbox Series X consoles in support of cancer research.

Akoya-biosciences
University-of-queensland-dr-arutha-kulasinghe
Microsoft-experience-centre-in-westfield-sydney
Cure-cancer
Nanostring-technologies
Microsoft-experience-centre
Westfield-sydney

Three Colorful Custom Xbox Series X Models Are On Auction For Cancer Research

Three Colorful Custom Xbox Series X Models Are On Auction For Cancer Research
gamespot.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gamespot.com Daily Mail and Mail on Sunday newspapers.

New-zealand
Australia
Australian
Akoya-biosciences
Arutha-kulasinghe
Ronnie-landfield
University-of-queensland
Microsoft-experience-center-at-westfield-sydney
Xbox-australia
Microsoft-experience-center
Cure-cancer

Kent Lake Capital LLC Sells 629,686 Shares of Akoya Biosciences, Inc. (NASDAQ:AKYA)

Kent Lake Capital LLC lowered its holdings in shares of Akoya Biosciences, Inc. (NASDAQ:AKYA – Free Report) by 84.3% in the 4th quarter, Holdings Channel.com reports. The fund owned 116,835 shares of the company’s stock after selling 629,686 shares during the period. Kent Lake Capital LLC’s holdings in Akoya Biosciences were worth $570,000 at the […]

United-states
America
Brian-mckelligon
Akoya-biosciences
Asia-pacific
Blackrock-inc
Nasdaq
Unisuper-management-pty-ltd
Kennedy-capital-management
Kent-lake-capital
Canaccord-genuity-group
Akoya-biosciences-inc

vimarsana © 2020. All Rights Reserved.